A detailed history of Wedmont Private Capital transactions in Novartis Ag stock. As of the latest transaction made, Wedmont Private Capital holds 6,190 shares of NVS stock, worth $600,925. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,190
Previous 5,874 5.38%
Holding current value
$600,925
Previous $625,000 13.76%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$106.13 - $120.89 $33,537 - $38,201
316 Added 5.38%
6,190 $711,000
Q2 2024

Jul 15, 2024

BUY
$92.57 - $107.37 $79,332 - $92,016
857 Added 17.08%
5,874 $625,000
Q1 2024

Apr 10, 2024

BUY
$95.27 - $108.47 $762 - $867
8 Added 0.16%
5,017 $485,000
Q4 2023

Jan 09, 2024

BUY
$92.27 - $101.54 $117,921 - $129,768
1,278 Added 34.25%
5,009 $505,000
Q3 2023

Oct 10, 2023

BUY
$94.73 - $105.13 $78,815 - $87,468
832 Added 28.7%
3,731 $380,000
Q2 2023

Jul 17, 2023

BUY
$92.52 - $104.91 $268,215 - $304,134
2,899 New
2,899 $292,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wedmont Private Capital Portfolio

Follow Wedmont Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Wedmont Private Capital with notifications on news.